OPKO HEALTH (OPK)
BioReference® Launches BioReferenceDirect™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
BioReference® Launches BioReferenceDirect™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak signals • Minimal impact expected **Sentiment:** Neutral (50%) **Content type:** General